Audit of a Clinical Trial Site

8/2/2019 Audit of a Clinical Trial Site

http://slidepdf.com/reader/full/audit-of-a-clinical-trial-site 1/30

3/10/12

Audit of a Clinical Trial

Site



Click to edit Master subtitle style

3/10/12

What is Audit ?



3/10/12

ICH GCP 1.6 Audit

A systematic and independent examination

of trial-related activities anddocuments

to determine whether the evaluated

trial related activities wereconducted, and the data wererecorded, analyzed and accurately

reported according to the protocol,s onsor’s standard o eratin




3/10/12

Type of audits



3/10/12

Routine

To assure compliance with

sponsor,

federal and local regulations



3/10/12

“For cause”

Auditing group has evidence orsuspects non-compliance with

some aspect of the clinical trialrequirements




3/10/12

Who conducts audits ?


http://slidepdf.com/reader/full/audit-of-a-clinical-trial-site 8/303/10/12

Who conducts audits ?

Sponsor regulatory departmentrepresentatives

International regulatoryauthorities

US FDA

EU Authorities (UK, France)




3/10/12

When audits occur ?



When audits occur ?

During the trial

After the trial has beencompleted




3/10/12

Why ?



Regulatory requirement

ICH GCP 5.19

Indian GCP 3.1.14

Sponsor should perform audit as apart of QA system




3/10/12

Sponsor audit



Sponsor Audit Visit

Typically conducted by sponsorregulatory department

An independent examination of trial-related activities anddocuments



Sponsor Audit VisitObjectives and Goals

Assure subject rights andwelfare are being adequatelyprotected

Assess investigator sitecompliance to protocol

Assure regulatory compliance

Assess sponsor monitoring



3/10/12

1. Auditor

2. Auditee

3. Audit plan

4. Sampling

5. Checklist6. Audit report

7. CAPA

8. Follow-up



3/10/12

Audit Visit Activities

Inspect facility

Review qualifications of staff

Discuss trial roles and

responsibilities of staff

Review trial document file



3/10/12

Preparation of audit



3/10/12



3/10/12

Face the audit



3/10/12

DON’T PANIC!Most likely, your site has beenchosen for inspection becausethe data are felt to have been animportant contribution to thetrial conclusion



3/10/12

Responding to anAuditor

Request to see identification

Identify which trial the auditorwants to inspect

Retrieve the CRF’s and trialdocument file for that specifictrial




3/10/12

Common Audit Findings



3/10/12

Protocol noncompliance

Inadequate source documents

Inadequate investigational

product(s) records

Informed consent issues



3/10/12

Common Audit Findings:Protocol Noncompliance

Serious adverse event or deathsnot reported in timely manner

Inclusion or exclusion criteriaviolated

Prohibited concomitantmedications taken

o o u s:



3/10/12

o o u s:Inadequate Source

DocumentsDocuments for all subjects notavailable

Records on screen failures notmaintained

Discrepancies between CRF andsource documents

ommon u t F n ngs:



3/10/12

ommon u t F n ngs:Inadequate InvestigationalProduct(s) Records

No records of investigationalproduct(s) receipt and return

Investigational product(s) logand dosing in CRF inconsistent

Unclear documentation of theinvestigational product(s) thatsubjects forgot to return

C di i di



3/10/12

Common Audit Findings:Informed Consent Issues

Subject did not sign informedconsent form prior to protocolprocedures being performed

Subject failed to sign informedconsent form amendments

Informed consent form notproperly dated



3/10/12

Audit of a Clinical Trial Site

Documents

Transcript of Audit of a Clinical Trial Site